308 related articles for article (PubMed ID: 15942229)
21. Acquired dermal macular hyperpigmentation: an overview of the recent updates.
Shah S; Baskaran N; Vinay K; Bishnoi A; Parsad D; Kumaran MS
Int J Dermatol; 2023 Dec; 62(12):1447-1457. PubMed ID: 37767951
[TBL] [Abstract][Full Text] [Related]
22. [Chronic toxic erythemo-macular skin hyperpigmentation (erythema dyschromicum perstans, ashy dermatosis].
Samos-Zielińska J; Lańcucki J; Dabrowski J; Sadowska-Iwańciow H
Przegl Dermatol; 1979; 66(4):385-91. PubMed ID: 493562
[No Abstract] [Full Text] [Related]
23. Erythema dyschromicum perstans: report of a new case and critical review of the literature.
Combemale P; Faisant M; Guennoc B; Dupin M; Heyraud JD
J Dermatol; 1998 Nov; 25(11):747-53. PubMed ID: 9863289
[TBL] [Abstract][Full Text] [Related]
24. Lichen planus pigmentosus.
Sehgal VN; Verma P; Bhattacharya SN; Sharma S; Rasool F
Skinmed; 2013; 11(2):96-103. PubMed ID: 23745228
[TBL] [Abstract][Full Text] [Related]
25. Patch testing and histopathology in Thai patients with hyperpigmentation due to Erythema dyschromicum perstans, Lichen planus pigmentosus, and pigmented contact dermatitis.
Tienthavorn T; Tresukosol P; Sudtikoonaseth P
Asian Pac J Allergy Immunol; 2014 Jun; 32(2):185-92. PubMed ID: 25003734
[TBL] [Abstract][Full Text] [Related]
26. Small brown circles: an important diagnostic clue for pigmented squamous cell carcinoma.
Fraga-Braghiroli N; Stephens A; Oliviero M; Rabinovitz H; Scope A
J Am Acad Dermatol; 2013 Oct; 69(4):e161-3. PubMed ID: 24034384
[No Abstract] [Full Text] [Related]
27. Erythema dyschromicum perstans and lichen planus: are they related?
Berger RS; Hayes TJ; Dixon SL
J Am Acad Dermatol; 1989 Aug; 21(2 Pt 2):438-42. PubMed ID: 2754077
[TBL] [Abstract][Full Text] [Related]
28. Idiopathic eruptive macular pigmentation in a 7-year-old girl: case report and discussion of differences from erythema dyschromicum perstans.
Volz A; Metze D; Böhm M; Bruckner-Tuderman L; Nashan D
Br J Dermatol; 2007 Oct; 157(4):839-40. PubMed ID: 17714566
[No Abstract] [Full Text] [Related]
29. Non-ablative 1550 nm fractional laser therapy not effective for erythema dyschromicum perstans and postinflammatory hyperpigmentation: a pilot study.
Kroon MW; Wind BS; Meesters AA; Wolkerstorfer A; van der Veen JP; Bos JD; Van der Wal AC; Beek JF
J Dermatolog Treat; 2012 Oct; 23(5):339-44. PubMed ID: 21756152
[TBL] [Abstract][Full Text] [Related]
30. [Persistent dyschromic erythema].
Poljacki M; Duran V; Vucković N; Subotić M; Ivkov M; Matić M; Jovanović M
Med Pregl; 1999; 52(3-5):165-8. PubMed ID: 10518404
[TBL] [Abstract][Full Text] [Related]
31. Improvement of erythema dyschromicum perstans using a combination of the 1,550-nm erbium-doped fractionated laser and topical tacrolimus ointment.
Wolfshohl JA; Geddes ER; Stout AB; Friedman PM
Lasers Surg Med; 2017 Jan; 49(1):60-62. PubMed ID: 27552666
[TBL] [Abstract][Full Text] [Related]
32. Lichenoid tissue reactions. A speculative review of the clinical spectrum of epidermal basal cell damage with special reference to erythema dyschromicum perstans.
Pinkus H
Arch Dermatol; 1973 Jun; 107(6):840-6. PubMed ID: 4575946
[No Abstract] [Full Text] [Related]
33. Clinical and histological aspect of erythema dyschromicum perstans in Korea: A review of 68 cases.
Chang SE; Kim HW; Shin JM; Lee JH; Na JI; Roh MR; Lee JH; Lee GY; Ko JY
J Dermatol; 2015 Nov; 42(11):1053-7. PubMed ID: 26118942
[TBL] [Abstract][Full Text] [Related]
34. Two cases of lichen planus pigmentosus presenting with a linear pattern.
Hong S; Shin JH; Kang HY
J Korean Med Sci; 2004 Feb; 19(1):152-4. PubMed ID: 14966361
[TBL] [Abstract][Full Text] [Related]
35. Erythema Dyschromicum Perstans Response to Isotretinoin.
Wang F; Zhao YK; Wang Z; Liu JH; Luo DQ
JAMA Dermatol; 2016 Jul; 152(7):841-2. PubMed ID: 26933923
[No Abstract] [Full Text] [Related]
36. A case of linear lichen planus.
Kökçam I; Ozercan IH
J Dermatol; 2005 Sep; 32(9):756-8. PubMed ID: 16361721
[TBL] [Abstract][Full Text] [Related]
37. Lichen planus pigmentosus distributed along the lines of Blaschko.
Akarsu S; Ilknur T; Özer E; Fetil E
Int J Dermatol; 2013 Feb; 52(2):253-4. PubMed ID: 21349081
[No Abstract] [Full Text] [Related]
38. Case for diagnosis.
Cherobin AC; Oliveira FO; Baeta IG; Vale EC
An Bras Dermatol; 2012; 87(1):151-2. PubMed ID: 22481670
[TBL] [Abstract][Full Text] [Related]
39. Erythema dyschromicum perstans.
Tlougan BE; Gonzalez ME; Mandal RV; Kundu RV; Skopicki D
Dermatol Online J; 2010 Nov; 16(11):17. PubMed ID: 21163168
[TBL] [Abstract][Full Text] [Related]
40. HLA-DR association with the genetic susceptibility to develop ashy dermatosis in Mexican Mestizo patients.
Correa MC; Memije EV; Vargas-Alarcón G; Guzmán RA; Rosetti F; Acuña-Alonzo V; Martínez-Rodríguez N; Granados J
J Am Acad Dermatol; 2007 Apr; 56(4):617-20. PubMed ID: 17116345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
